By Stephanie Brown HealthDay ReporterMONDAY, Aug. 25, 2025 (HealthDay News) — The U.S. Food and Drug Administration is suspending the biologics license for the live-attenuated chikungunya vaccine, Ixchiq, in the United States. The move comes after r… [1843 chars]